Investors in GSK (LON:GSK) have unfortunately lost 8.3% over the last three years - Simply Wall St News
Why are GlaxoSmithKline (GSK) shares so low? (LON:GSK) - Good Money Guide
GlaxoSmithKline Pharmaceuticals Share: Motilal Oswal Financial Services neutral on GlaxoSmithKline Pharmaceuticals; target price: Rs 1300 - The Economic Times
Unilever Needs $10 Billion Bump to Win Glaxo Unit, Analysts Say - BNN Bloomberg
GSK falls victim to 'hard to please' pharma market | LSE:GSK, NYSE:GSK
GlaxoSmithKline to Acquire Tesaro for $4.16 Billion - WSJ
GlaxoSmithKline demerger: GSK spin-off Haleon date and details in full
Consumer goods arm of GSK hits stock market | This is Money
Glaxosmithkline Pharmaceuticals Share Price today, Market Cap, Shareholding, Financials
GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022
GSK spinoff starts trading at LSE - what you need to know
UK Drugmaker GSK Needs to Show It's Kicked the Dealmaking Addiction - Bloomberg
Drug wars: how AstraZeneca overtook GSK in UK pharma
GSK spins off Haleon in biggest European listing for a decade
Glaxo (GSK) to Report Q1 Earnings: What's in the Cards?
Elliott Publishes Letter on GlaxoSmithKline
GSK lines up Rs 6,400cr open offer - Times of India
GSK Needs to Show It's Kicked the Dealmaking Addiction - The Washington Post
GSK Stock Price and Chart — LSE:GSK — TradingView
Glaxo Underperforms Industry in a Year: What's in Store?
GSK (GSK) Stock Price, News & Info | The Motley Fool
Better Buy: Eli Lilly vs. GlaxoSmithKline | The Motley Fool
Glaxo (GSK) Q4 Earnings Top Estimates, Xevudy Adds $1.1B in Sales | Nasdaq
Leading UK pharma & biotech companies by market cap 2023 | Statista
Glaxo's (GSK) Q1 Earnings Top, Xevudy Adds $1.7B in Sales | Nasdaq
Haleon or GSK – which is the better play?
